TS IPASS

Powerful modern analysis tools for Biotechnology stocks.

[TS IPASS @biostocx]

#heycb Do you feel this young batting lineup is consistent?

IMO, Overall as a team it looks consistent, however no individual is consistent.

[TS IPASS @biostocx]

@Congress4TS Uncle meeru aunty ah ?

[TS IPASS @biostocx]

@AussiesArmy Hey man, polish them regularly with sandpaper to keep them shining.

[TS IPASS @biostocx]

@StocktwitsIndia Got back to the corrupted price.

[TS IPASS @biostocx]

Here we go!

[TS IPASS @biostocx]

$IRFC will be touching 185 Tomorrow

[TS IPASS @biostocx]

$IRFC will be touching 185 Tomorrow

[BiopharmIQ by Amp @BiopharmIQ]

🧬 Bio Twitter Weekly Recap 🧬

📣 Interesting posts/ppl to check out!

@Pharmdca
Six blockbuster STATIN drugs over time from 1990 to 2015
» https://t.co/5gYS7cKIaT

@mtheory11bio
$MREO seems to be catching a bid on $INSM stat...
» https://t.co/UKMCfBIIpq

@GeneInvesting
CRISPR Gene Editing- “The List”
» https://t.co/8E9hD2Dxuw

@yaireinhorn
Here’s a great video in which $CRSP CEO @CrisprSam explains...
» https://t.co/ys40EBJOLb

@fluffer9
$VKTX Wow. April 28th Truist Meeting notes...
» https://t.co/hnD01jVB0v

@TomSilver39
JPM:" 2024 US Biotech Outlook: J.P. Morgan top picks –
» https://t.co/vBzYukcxis

@Sports_bios
$BHVN has the full R&D Day presentation deck online now...
» https://t.co/O38Rcg9Scz

@Prof_Oak_
$REGN's treatment approach to food allergy...
» https://t.co/EBhZbRDXkI

@Andre_AGTC
Summary of WF 2024 list
» https://t.co/6KIxf2WI3e

@Quantumup1
Piper Sandler reiterated $IOVA Overweight/$19:
» https://t.co/zKhvsaApfN

@PropThinker
$AZN investor day slide showing >50% of global population...
» https://t.co/Brz2FjG8mT

@BowTiedBiotech
1/ Autoimmune: BCMAxCD19 CAR-T + IL15 sushi armor 🍣
» https://t.co/7NZqckFHBr

@ohadhammer
EULAR 2024 data highlights from Jefferies
» https://t.co/JGmK0pTUTh

@skathire
From human genetics validation to a drug at Phase 2:
» https://t.co/Rf7JlTHfy3

@BiopharmIQ
#ASCO2024 starts tomorrow 🗓️
» https://t.co/U5FSJ7Tmxy

@BioStocks
$DAWN sells Priority Review Voucher for $108M
» https://t.co/ek4lO22CpA

@ConradEnge98050
CXCL9 guides CD8+ T-cells to find and fight tumors...
» https://t.co/zOpwh0ILVa

@ilzizzo
Wells Fargo Securities published their annual list of small and mid cap...
» https://t.co/YgoeeIjg4b

@crypto_biotech
$ARDX Interesting well thought out tin foil hat ideas...
» https://t.co/kPIjquT1VJ

@dub_k1
$PDSB updated OS chart...
» https://t.co/1x3KuV15ak

@_BiotechMD
$IOVA upcoming 31May ASCO oral presentation/detailed data...
» https://t.co/rw0M9Sz9pO

@DueDoctor
Over ~billion dollars worth of loss at Karyopharm
» https://t.co/rMGOYITmCQ

@Gantosj
For me, the most important data that I'm expecting from $MDNAF...
» https://t.co/YjpkslDT8S

@PersimmonTI
$XBI — the usual suspects
» https://t.co/5bzMAUKsEW

@learnbiotech
Many recent approvals from large pharma...
» https://t.co/ACk99fjI6t

@LTbioinvestor
#biotechs red for the year, with markets flying ...
» https://t.co/2M7XUyBoAw

@paras_biotech
From Stifel - Biggest one month moves in Biotech
» https://t.co/UTsuW8MJhq

[TS IPASS @biostocx]

@DipeshUpretyMD @OncoAlert @BTFCancerNews @OncBrothers @ADesaiMD @RManochakian @StephenVLiu @PatelOncology @n8pennell @JackWestMD @FordePatrick @kaushalpar I found them here !

[BiopharmIQ by Amp @BiopharmIQ]

Which #ASCO2024 smid-cap(s) is likely to MOVE BIG THIS WEEK? 👇

We're keeping a close eye on 19 smid-cap biotechs with Ph1 readouts.

Even an early Ph1 can move a stock with impressive early data
- As proof of concept for new technology area
- If meeting long-felt need
- If looking better than a successful approved product
- Especially if in a hot tech area like ADCs, radiopharma, bi-specifics, etc.

Could one of these smid-cap underdogs steal the show? 🤔

Check out the image for more details 📸

Check out our comment for access to our free ASCO investor tool 👇

#ASCO24 #biotech #oncology #cancerresearch $XBI $IBB

[BiopharmIQ by Amp @BiopharmIQ]

Which #ASCO2024 smid-cap(s) is likely to MOVE BIG THIS WEEK? 👇

We're keeping a close eye on 19 smid-cap biotechs with Ph1 readouts.

Even an early Ph1 can move a stock with impressive early data
- As proof of concept for new technology area
- If meeting long-felt need
- If looking better than a successful approved product
- Especially if in a hot tech area like ADCs, radiopharma, bi-specifics, etc.

Could one of these smid-cap underdogs steal the show? 🤔

Check out the image for more details 📸

Check out our comment for access to our free ASCO investor tool 👇

#ASCO24 #biotech #oncology #cancerresearch $XBI $IBB

[TS IPASS @biostocx]

@JacobPlieth I found something interesting 🧐

https://t.co/q18N5dovxP

[BiopharmIQ by Amp @BiopharmIQ]

Which #ASCO2024 smid-cap(s) is likely to MOVE BIG THIS WEEK? 👇

We're keeping a close eye on 19 smid-cap biotechs with Ph1 readouts.

Even an early Ph1 can move a stock with impressive early data
- As proof of concept for new technology area
- If meeting long-felt need
- If looking better than a successful approved product
- Especially if in a hot tech area like ADCs, radiopharma, bi-specifics, etc.

Could one of these smid-cap underdogs steal the show? 🤔

Check out the image for more details 📸

Check out our comment for access to our free ASCO investor tool 👇

#ASCO24 #biotech #oncology #cancerresearch $XBI $IBB

[TS IPASS @biostocx]

@StocktwitsIndia It was supposed to be a hidden gem until I buy it.

[TS IPASS @biostocx]

@GemsOfKCR Aree yaar .. What about 40% Sarkar?

[TS IPASS @biostocx]

@TeluguScribe Nice 👍🏻… Hope they will get all schemes.

[TS IPASS @biostocx]

@themangoindian Gundu pelipoindi ani marichipoyara

[The Indian Index @IndianIndex]

GSDP Growth Rate, FY 2022 (in %):

Telangana: 11.97%
Kerala: 11.93%
J&K: 11.09%
Rajasthan: 11.36%
Haryana: 11.32%
Odisha: 11.26%
Andhra: 11.23%
Karnataka: 10.96%
Jharkhand: 10.87%
West Bengal: 10.76%
Gujarat: 10.56%
Madhya Pradesh: 10.43%
Uttar Pradesh: 10.20%
Delhi: 9.14%
Maharashtra: 9.13%
Bihar: 8.46%
CG: 8.46%
Uttarakhand: 8.19%
Assam: 8.06%
Tamil Nadu: 7.92%
Himachal: 7.55%
Punjab: 6.51%
Goa: 4.10%

$At Constant Prices (Base Year: 2011-12)
(MoSPI via. State Govts)

[TS IPASS @biostocx]

@GemsOfKCR Please comment on Sakshi, aaj Tak, tv5, abn, ndtv, aadani channels, q news, thanks. Let media be exposed.

[TS IPASS @biostocx]

@FIAFormulaE Jaffa Mestri

[TS IPASS @biostocx]

@GemsOfKCR Please post this as well https://t.co/5zF4tC9fuN

[TV9 Telugu @TV9Telugu]

మంచిర్యాల ఎమ్మెల్యే మా ల్యాండ్‌ కబ్జా చేస్తున్నారు | Praja Palana - TV9

#Prajapalana #telangana #tv9telugu

[TS IPASS @biostocx]

@angrybirdtweetz So are you ….

[TS IPASS @biostocx]

@Dhana38405223 @SaritaTNews @BRSHarish Honest Mallana…